Cardiology Update London 2018
Invitation
Dear Colleagues
It is a real pleasure to announce the 2nd Postgraduate Course of the Royal Brompton and Harefield NHS Foundation Trust & Imperial College, the Cardiology Update London.
Cardiology and cardiovascular medicine in general, is a rapidly expanding field with impressive developments and innovations over the last years. For physicians, be it general practitioners, cardiologists or cardiac surgeons, it is therefore important to keep pace with a challenging environment. To that end, we have designed a postgraduate course, the Cardiology Update London, to summarize, at the end of the year, the most important new developments, innovations, but also failures that will all affect cardiovascular diagnosis and management in our everyday practice.
We have selected an international faculty of high standing experts both from the Trust and worldwide, covering the entire spectrum of cardiovascular medicine from prevention to intervention, from valvular heart disease to heart failure, and from conservative management to intervention and surgical operations. Thus, the course will give an up-to-date overview about current diagnosis and management of the most important cardiovascular conditions during two days in London.
We would be most happy to welcome you at the Royal Society of Medicine in central London to enjoy two days of interactive education for the benefit of your practice and your patients.
Yours sincerely,
Prof. Thomas F. Lüscher
MD, FRPC, FESC
Dr. Richard Grocott-Mason
MD, FRCP
Prof. Kim Fox
MD, FRCP, FESC
Dr. Ruth Amstein
FESC
Programme
Program Monday
Program Tuesday
Monday, December 17th, 2018
Venue: Royal Society of Medicine, London
08:30 - 08:45 | Welcome Address | ||
08.30 | The Royal Brompton & Harefield Hospital Trust | K. Fox and T.F. Lüscher |
08:45 - 10:15 | Opening Lectures: From the Past to the Future Chairs: K. Fox and R. Grocott-Mason, London |
||
08:45 | Clonal Hematopoiesis: A potent newly recognized cardiovascular risk factor | P. Libby, Boston |
09:15 | Tailor-made decision making on surgical or percutaneous revascularisation based on non-invasive imaging and comorbidities | P. Serruys, Rotterdam |
09:45 | Heart failure 10 years from now: What are the expectations? | M. Packer, Dallas |
10:15-10:45 | COFFEE BREAK |
10:45 - 13:00 | Session 1: Risk Factors and Prevention Chairs: J.J. Bax, P. Libby and J.M. Shah |
||
10:45 | Hypertension: the new ESC Guidelines | M.D. Lobo, London |
11:05 | Device-based therapies for hypertension | F. Mahfoud, Homburg, Saar |
11:25 | The ESC Guidelines on lipid management: What is valid and what needs to be changed? | U. Landmesser, Berlin |
11:45 | PCSK9 inhibition: from genetics to therapeutics | P.G. Steg, Paris |
12:05 | Diabetes and cardiovascular disease | N. Poulter, London |
12:25 | Discussion | |
13:00-14:00 | LUNCH BUFFET |
14:00 - 16:00 | Session 2: Angina and ACS / Cardio-Oncology Chairs: U. Landmesser and K. Mohan |
||
14:00 | Cancer patients and HF | A. Lyon, London |
14:20 | The best imaging modalities to diagnose CAD | J.J. Bax, Leiden |
14:40 | PCI versus CABG in Stable CAD: Patient selection based on evidence | B. Gersh, Rochester |
15:00 | DAPT or anticoagulation: ESC Guidelines and the new field of thrombocardiology | P.G. Steg, Paris |
15:20 | Non-obstructive CAD, MINOCA | A. Lerman, Rochester |
15:40 | Discussion | |
16:00-16:30 | COFFEE BREAK |
16:30 - 18:00 | Session 3: Arrhythmias Chairs: B. Gersh, S. Haldar and A.G. Ballani |
||
16:30 | What is new in AF management? Antiarrhythmic drugs and NOACs | A.J. Camm, London |
16:50 | Atrial fibrillation ablation: expanding indications | S. Ernst, London |
17:10 | Towards precision medicine in the prevention of genetically-mediated sudden death | J. Brugada, Barcelona |
17:30 | Diagnosis and management of syncopies: the new ESC Guidelines | M. Brignole, Lavagna |
17:50 | Discussion | |
18:15 | COCKTAIL RECEPTION |
Tuesday, December 18th, 2018
Venue: Royal Society of Medicine, London
08:30 - 10:30 | Session 4: Valvular Heart Disease / ACS Chairs: T.F. Lüscher and S. Windecker |
||
08.30 | The role of imaging in valve disease | J.J. Bax, Leiden |
08.50 | TAVI: current indications and future developments | B. Prendergast, London |
09.10 | An interesting patient with aortic stenosis | O. Samara, London |
09:25 | Mitral valve repair: surgery or intervention? | G. Nickenig, Bonn |
09:45 | Management of ACS today, including ESC Guidelines on myocardial revascularisation | S. Windecker, Berne |
10:10 | Discussion | |
10:30-11:00 | COFFEE BREAK |
11:00 - 12:15 | Session 5: Heart Failure - Classification, Assessment and Treatment Chairs: M. Packer, M. Pfeffer and B.K. Mishra |
||
11.00 | Classification of heart failure according to the ESC Guidelines | J. Cleland, Glasgow |
11.20 | A clinical case of heart failure | H.O. Savage, Basildon |
11.35 | Treatment of heart failure: Drugs and devices | M. Cowie, London |
12:00 | Discussion | |
12:15-13:15 | LUNCH BUFFET |
13:15 - 14:45 | Session 6: Heart Failure and Comorbidities Chairs: M. Cowie and A. Maisel |
||
13.15 | Diabetes and HF | M. Packer, Dallas |
13.40 | Atrial fibrillation and HF: an evil conspiracy | J. Cleland, Glasgow |
14.05 | Pharmacological management of HFrEF | M. Pfeffer, Boston |
14:30 | Discussion | |
14.45-15:15 | COFFEE BREAK |
15:15 - 16:30 | Session 7: Cardiomyopathies/Heart Failure Chairs: J. Cleland and P. Kalra |
||
15.15 | The role of biomarkers in heart failure | A. Maisel, San Diego/Basel |
15.35 | Sudden cardiac death in HCM: Pathophysiology, risk stratification and management | B. Gersh, Rochester |
15.55 | Hereditary cardiomyopathies and HF | S. Prasad, London |
16:15 | Discussion |
16:30 - 17:00 | The Paul Hamilton Wood Lecture Chairs: K. Fox and T.F. Lüscher |
||
16:30 | Ventricular remodeling: a personal jouney | M. Pfeffer, Boston |
17:00 | Wrap-up and Close | T. F. Lüscher, London |
Speakers
Anil G. Ballani
Mumbai, IND
Jeroen J. Bax
Leiden, NL
Michele Brignole
Lavagna, IT
Josep Brugada
Barcelona, ES
A. John Camm
London, GB
John Cleland
Glasgow, GB
Martin Cowie
London, GB
Sabine Ernst
London, GB
Kim Fox
London, GB
Bernard Gersh
Rochester MN, US
Richard Grocott-Mason
London, GB
Shouvik Haldar
London, GB
Jay M. Shah
Ahmedabad, IND
Paul Kalra
Havant, GB
Ulf Landmesser
Berlin, DE
Amir Lerman
Rochester MN, US
Peter Libby
Boston, US
Melvin D. Lobo
London, GB
Thomas F. Lüscher
London, GB/Zurich, CH
Alexander Lyon
London, GB
Felix Mahfoud
Homburg Saar, DE
Alan Maisel
San Diego, US/Basel, CH
Bijay K. Mishra
Bhubaneshwar, IND
Krishnamurthy Mohan
Chennai, IND
Georg Nickenig
Bonn, DE
Milton Packer
Dallas, US
Marc Pfeffer
Boston, US
Neil Poulter
London, GB
Sanjay Prasad
London, GB
Bernard Prendergast
London, GB
Osama Samara
London, GB
Henry Oluwasefunmi Savage
Basildon, GB
Patrick Serruys
Rotterdam, NL
P. Gabriel Steg
Paris, FR
Stephan Windecker
Berne, CH
Information
Registration
Category | Price |
---|---|
Registration fees | |
Regular fee | GBP 300 |
Early registration fee (before November 24, 2018) | GBP 250 |
Trainees/Residents, Research fellows, Nurses, Students <35 years (ID proof required) | |
Regular fee | GBP 150 |
Early registration fee (before November 24, 2017) | GBP 100 |
Day ticket | GBP 150 |
Register online. Deadline for registration: 12 December 2018
For group registrations a minimum number of 10 participants is required. Please contact Nadine-Estelle Kaltheuner to obtain further information.
Registration will be confirmed upon receipt of payment.
Please note that UK banks may charge high fees for international bank transfers. We therefore recommend payment by credit card.
Modification & Cancellation
All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 50 will be charged for administrative costs. In case of cancellation up to 1st November 2018, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.
Organisation
Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Nadine-Estelle Kaltheuner
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90
Venue
The Royal Society of Medicine
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom
Accreditation
The Cardiology Update London has been approved by:
Federation of the Royal Colleges of Physicians of the United Kingdom for CPD credits
14 category 1 (external) CPD credits
EACCME-UEMS
European Accreditation Council for Continuing Medical Education (EACCME)
13 European CME credits (ECMECs)
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Recommended by the British Cardiovascular Society